Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

656 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identification of BRCA1/2 mutation female carriers using circulating microRNA profiles.
Elias K, Smyczynska U, Stawiski K, Nowicka Z, Webber J, Kaplan J, Landen C, Lubinski J, Mukhopadhyay A, Chakraborty D, Connolly DC, Symecko H, Domchek SM, Garber JE, Konstantinopoulos P, Fendler W, Chowdhury D. Elias K, et al. Among authors: chowdhury d. Nat Commun. 2023 Jun 8;14(1):3350. doi: 10.1038/s41467-023-38925-4. Nat Commun. 2023. PMID: 37291133 Free PMC article.
Association of microRNAs and pathologic response to preoperative chemotherapy in triple negative breast cancer: preliminary report.
Kolacinska A, Morawiec J, Fendler W, Malachowska B, Morawiec Z, Szemraj J, Pawlowska Z, Chowdhury D, Choi YE, Kubiak R, Pakula L, Zawlik I. Kolacinska A, et al. Among authors: chowdhury d. Mol Biol Rep. 2014 May;41(5):2851-7. doi: 10.1007/s11033-014-3140-7. Epub 2014 Jan 29. Mol Biol Rep. 2014. PMID: 24469723 Free PMC article.
A functional screen identifies miRs that induce radioresistance in glioblastomas.
Moskwa P, Zinn PO, Choi YE, Shukla SA, Fendler W, Chen CC, Lu J, Golub TR, Hjelmeland A, Chowdhury D. Moskwa P, et al. Among authors: chowdhury d. Mol Cancer Res. 2014 Dec;12(12):1767-78. doi: 10.1158/1541-7786.MCR-14-0268. Epub 2014 Sep 25. Mol Cancer Res. 2014. PMID: 25256711 Free PMC article.
Platinum and PARP Inhibitor Resistance Due to Overexpression of MicroRNA-622 in BRCA1-Mutant Ovarian Cancer.
Choi YE, Meghani K, Brault ME, Leclerc L, He YJ, Day TA, Elias KM, Drapkin R, Weinstock DM, Dao F, Shih KK, Matulonis U, Levine DA, Konstantinopoulos PA, Chowdhury D. Choi YE, et al. Among authors: chowdhury d. Cell Rep. 2016 Jan 26;14(3):429-439. doi: 10.1016/j.celrep.2015.12.046. Epub 2016 Jan 7. Cell Rep. 2016. PMID: 26774475 Free PMC article.
Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer.
Strickland KC, Howitt BE, Shukla SA, Rodig S, Ritterhouse LL, Liu JF, Garber JE, Chowdhury D, Wu CJ, D'Andrea AD, Matulonis UA, Konstantinopoulos PA. Strickland KC, et al. Among authors: chowdhury d, d andrea ad. Oncotarget. 2016 Mar 22;7(12):13587-98. doi: 10.18632/oncotarget.7277. Oncotarget. 2016. PMID: 26871470 Free PMC article.
656 results